Atrial fibrillation (AF), the most commonly encountered clinical arrhythmia, often complicates
acute myocardial infarction (AMI) with an incidence between 6 and 21%. Predictors of the …

This consensus guideline was prepared on behalf of the International Society for Holter and
Noninvasive Electrocardiology and is cosponsored by the Japanese Circulation Society, the …

Sudden cardiac death (SCD) remains a daunting problem. It is a major public health issue
for several reasons: from its prevalence (20% of total mortality in the industrialized world) to …

Background Vitamin K antagonists are highly effective in preventing stroke in patients with
atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor …

ESC Guidelines 2721 the outcome of disease may be favourably influenced by the thorough
application of clinical recommendations. Thus, the task of writing guidelines covers not only …

Background Vitamin K antagonists have been shown to prevent stroke in patients with atrial
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …

Background One quarter of strokes are of unknown cause, and subclinical atrial fibrillation
may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial …

Background Cardiac-resynchronization therapy (CRT) benefits patients with left ventricular
systolic dysfunction and a wide QRS complex. Most of these patients are candidates for an …

Background It is common practice to restore and maintain sinus rhythm in patients with atrial
fibrillation and heart failure. This approach is based in part on data indicating that atrial …

Background Atrial fibrillation is the most commonly encountered sustained cardiac arrhythmia.
Restoration and maintenance of sinus rhythm is believed by many physicians to be …